Loading...
•
Jun 30
Option Care Health Q2 2025 Earnings Report
Option Care Health's financial results for the second quarter ended June 30, 2025, were announced, showing increased net revenue and adjusted diluted EPS, despite a slight decrease in net income.
Key Takeaways
Option Care Health reported a strong second quarter in 2025, with net revenue increasing by 15.4% to $1,416.1 million and adjusted diluted earnings per share rising by 10.8% to $0.41. While net income saw a slight decrease, the company demonstrated resilience and continued to focus on providing strong clinical outcomes.
Net revenue for Q2 2025 reached $1,416.1 million, marking a 15.4% increase from $1,227.2 million in Q2 2024.
Adjusted diluted earnings per share grew by 10.8% to $0.41 in Q2 2025, up from $0.37 in Q2 2024.
Gross profit increased by 7.9% to $269.0 million in Q2 2025, compared to $249.4 million in the same period last year.
Adjusted EBITDA rose by 5.2% to $114.0 million in Q2 2025, from $108.4 million in Q2 2024.
Option Care Health
Option Care Health
Forward Guidance
For the full year 2025, Option Care Health expects net revenue between $5.50 billion and $5.65 billion, adjusted diluted earnings per share of $1.65 to $1.72, and adjusted EBITDA of $465 million to $475 million. Cash flow from operations is projected to be at least $320 million.
Positive Outlook
- Expected net revenue for full year 2025 is strong, ranging from $5.50 billion to $5.65 billion.
- Adjusted diluted earnings per share are projected to be between $1.65 and $1.72 for the full year 2025.
- Adjusted EBITDA is anticipated to be robust, in the range of $465 million to $475 million for 2025.
- Cash flow from operations is expected to be at least $320 million, indicating healthy operational cash generation.
- The company anticipates an effective tax rate of 25% - 27%, providing clarity on future tax liabilities.
Challenges Ahead
- Net interest expense is projected to be approximately $55 million to $60 million, which will impact profitability.
- The guidance does not provide specific details on potential challenges or risks that could affect these projections.
- No specific negative factors were highlighted in the forward guidance section of the report.
- The report does not specify any potential headwinds or increased costs that could impact the full year outlook.
- The guidance does not include any specific warnings about market volatility or economic downturns.